Sitosterolemia: A new mutation in a Mediterranean patient

Journal of Clinical Lipidology

Volumn 8, Issue 4, 2014, Pages 451-454

  Melenotte, Cléa ^a   Carrié, Alain ^a,b,c   Serratrice, Jacques ^a   Weiller, Pierre Jean ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Mediterranean diet; Phytosterolemia; Sitosterolemia

Indexed keywords

ABC TRANSPORTER G5; EZETIMIBE; SIMVASTATIN; STEROL; ABC TRANSPORTER; ABCG5 PROTEIN, HUMAN; AZETIDINE DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN; PHYTOSTEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; AUTOSOMAL RECESSIVE DISORDER; BLOOD LEVEL; CASE REPORT; FEMALE; GENE MUTATION; HEMOLYTIC ANEMIA; HUMAN; INTESTINE CELL; MEDITERRANEAN DIET; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SITOSTEROLEMIA; THROMBOCYTOPENIA; ADVERSE EFFECTS; ANEMIA; FRANCE; GENETICS; HYPERCHOLESTEROLEMIA; INTESTINAL DISEASES; LIPID METABOLISM, INBORN ERRORS; MUTATION; PHYSIOLOGY;

ANEMIA; ANTICHOLESTEREMIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; AZETIDINES; DIET, MEDITERRANEAN; DNA MUTATIONAL ANALYSIS; ENTEROCYTES; FEMALE; FRANCE; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINAL DISEASES; LIPID METABOLISM, INBORN ERRORS; LIPOPROTEINS; MIDDLE AGED; MUTATION; PHYTOSTEROLS; SIMVASTATIN; THROMBOCYTOPENIA;

EID: 84905900666     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2014.06.003     Document Type: Article

References (19)

1. Mente A, De Koning L, Shannon HS, et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Int Med. 2009;169:659-669.
2. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368: 1279-1290.
3. Bhattacharyya AK, Connor WE. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest. 1974;53:1033-1043.
4. Kidambi S, Patel SB. Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis. J Clin Pathol. 2008;61:588-594.
5. Othman RA, Myrie SB, Jones PJ. Non-cholesterol sterols and cholesterol metabolismin sitosterolemia. Atherosclerosis. 2013;231:291-299.
6. Rees DC, Iolascon A, Carella M, et al. Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia. Br J Haematol. 2005;130:297-309.
7. Yu XH, Qian K, Jiang N, et al. ABCG5/ABCG8 in cholesterol excretion and atherosclerosis. Clin Chim Acta. 2014;428:82-88.
8. Jia L, Betters JL, Yu L. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Ann Rev Phys. 2011;73: 239-259.
9. Kanaji T, Kanaji S, Montgomery RR, et al. Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia. Blood. 2013;122:2732-2742.
10. Alam M, Garzon MC, Salen G, et al. Tuberous xanthomas in sitosterolemia. Pediatr Dermatol. 2000;17:447-449.
11. Cobb MM, Salen G, Tint GS, et al. Sitosterolemia: opposing effects of cholestyramine and lovastatin on plasma sterol levels in a homozygous girl and her heterozygous father. Metabolism. 1996;45:673-679.
12. Rios J, Stein E, Shendure J, et al. Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia. Hum Mol Genet. 2010;19:4313-4318.
13. Yoshida A, Naito M, Miyazaki K. Japanese sisters associated with pseudohomozygous familial hypercholesterolemia and sitosterolemia. J Atheroscler Thromb. 2000;7:33-38.
14. Wang Z, Cao L, Su Y, et al. Specific macrothrombocytopenia/hemolytic anemia associatedwith sitosterolemia. AmJ Hematol. 2014;89:320-324.
15. Salen G, Xu G, Tint GS, et al. Hyperabsorption and retention of campestanol in a sitosterolemic homozygote: comparison with her mother and three control subjects. J Lipid Res. 2000;41:1883-1889.
16. Katayama T, Satoh T, Yagi T, et al. A 19-year-old man with myocardial infarction and sitosterolemia. Intern Med. 2003;42:591-594.
17. Tsubakio-Yamamoto K, Nishida M, Nakagawa-Toyama Y, et al. Current therapy for patients with sitosterolemia-effect of ezetimibe on plant sterol metabolism. J Atheroscler Thromb. 2010;17:891-900.
18. Salen G, von Bergmann K, Lutjohann D, et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation. 2004;109:966-971.
19. Musliner T, Cselovszky D, Sirah W, et al. Efficacy and safety of ezetimibe 40 mg vs. ezetimibe 10 mg in the treatment of patients with homozygous sitosterolaemia. Int J Clin Pract. 2008;62:995-1000.